No Data
No Data
No Data
No Data
No Data
Quoin Pharmaceuticals Is Maintained at Buy by Maxim Group
Quoin Pharmaceuticals Is Maintained at Buy by Maxim Group
Dow JonesMar 15 11:25 ET
Express News | Maxim Group Maintains Buy on Quoin Pharmaceuticals, Lowers Price Target to $4
Moomoo 24/7Mar 15 11:15 ET
Quoin Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/15/2024 327.76% Maxim Group $15 → $4 Maintains Buy 09/07/2022 2038.81% Alliance Global Partners → $20 I
BenzingaMar 15 11:13 ET
Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q4 2023 Earnings Call Transcript
Yahoo FinanceMar 15 10:52 ET
Earnings Call: Quoin Pharmaceuticals Reports Q4 Progress and Outlook
InvestingMar 14 21:26 ET
Earnings Call Summary | Quoin Pharmaceuticals(QNRX.US) Q4 2023 Earnings Conference
The following is a summary of the Quoin Pharmaceuticals, Ltd. (QNRX) Q4 2023 Earnings Call Transcript:Financial Performance:Quoin Pharmaceuticals Ltd ended the year with around $10.7 million cash and
moomoo AIMar 14 13:45 ET · Conference Call
MDR81 : I stuck at 1.5 average, I don't have much confident ER positive.. what is your advice @Mcsnacks H Tupack
taijahmed75 MDR81: It’s a blood bath today, I didn’t expect that it will come down below.90, I’m bit tensed now. @Mcsnacks H Tupack @Trytosaveabit can you pls give us your valuable input here?
PortoCall : I saw their share offering - what’s your input on that move? Wondering if I should take it or hold it.
RockaphobicOP PortoCall:
ASHBURN, Va. - Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a specialty pharmaceutical company, has announced the pricing of a public offering aimed at raising approximately $6.5 million. The offering includes 4,062,500 shares, each represented by American Depositary Shares (ADS), and warrants for purchasing additional shares.
The combined purchase price for one ADS and associated Series D and Series E warrants is $1.60. These warrants, exercisable immediately upon issuance, are priced at $1.60 per share and will expire two and five years from the date of issuance, respectively. The company expects the offering to close on or about March 7, 2024, subject to standard closing conditions.
RockaphobicOP : On March 13th, they'll be releasing their earnings report. My guess is that it will be all the fuel this will need to take a trip to the . Hope your are packed. The 14th will come fast.
No Data
No Data